Statements (56)
Predicate | Object |
---|---|
gptkbp:instanceOf |
organization
|
gptkbp:collaboratesWith |
gptkb:World_Health_Organization
gptkb:European_Medicines_Agency |
gptkbp:conducts |
inspections
|
gptkbp:country |
gptkb:United_Kingdom
|
gptkbp:engagesIn |
public consultations
|
gptkbp:established |
2003
|
gptkbp:formFactor |
gptkb:Medicines_and_Healthcare_products_Regulatory_Agency
|
gptkbp:hasAuthorityOver |
clinical research
|
gptkbp:hasDepartment |
Clinical Trials
Inspection Medical Devices Licensing Pharmacovigilance |
gptkbp:hasFeature |
pharmaceutical companies
patients medical device manufacturers healthcare_providers |
gptkbp:hasImpactOn |
public health policy
|
gptkbp:hasRole |
public health
|
gptkbp:hasWebsite |
www.gov.uk/mhra
|
gptkbp:headquarters |
gptkb:London
|
https://www.w3.org/2000/01/rdf-schema#label |
MHRA
|
gptkbp:isAccessibleBy |
gptkb:Parliament
|
gptkbp:isFundedBy |
gptkb:UK_government
|
gptkbp:isInvolvedIn |
research funding
healthcare_regulation |
gptkbp:isLedBy |
Chief Executive
|
gptkbp:isPartOf |
UK_health_system
|
gptkbp:isRecognizedBy |
international regulatory bodies
|
gptkbp:issues |
guidance documents
drug safety alerts guidance on COVID-19 vaccines guidance on drug safety guidance on medical device safety |
gptkbp:manages |
pharmacovigilance
|
gptkbp:monitors |
adverse drug reactions
|
gptkbp:oversees |
clinical trials
|
gptkbp:participatesIn |
international collaborations
|
gptkbp:promotes |
patient safety
|
gptkbp:provides |
safety information
training for healthcare professionals information for patients regulatory advice information for healthcare professionals |
gptkbp:providesGuidanceOn |
clinical trials
medical device regulations drug licensing |
gptkbp:publishes |
annual reports
|
gptkbp:regulates |
medical devices
medicines |
gptkbp:responsibleFor |
safety of medical devices
safety of medicines |
gptkbp:supports |
innovation in healthcare
|
gptkbp:worksWith |
gptkb:Department_of_Health_and_Social_Care
gptkb:NHS |